Management of Vulval Cancer Services in South West England Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour.

Slides:



Advertisements
Similar presentations
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Advertisements

Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.
National Prostate Cancer Audit: Review of the Organisational Audit Dr Ajay Aggarwal Oncology Coordinator NPCA Honorary.
West Midlands Cancer Intelligence Unit Extending Quality Assurance to all Breast Cancers: the BCCOM Project UKACR Annual Conference 29 September 2004 Gill.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Trust Cancer Lead Clinician
Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Teenagers and Young Adults with Cancer Chemotherapy Conference 19 th March 2009 Linda Devereux Associate Director.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
JCUH NICE MSCC Guidelines Compliance audit Ruth Mhlanga Senior Specialist Physiotherapist Oncology and Haematology.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.
PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.
BCCs & GPs Dr Victoria Brown Consultant Dermatologist West Hertfordshire Hospitals NHS Trust.
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
MBCG Project Primary Results MEDICALSURVEYS-17 RESEARCH GROUP IN COLLABORATION WITH THE EASO.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
BRIGHTLIGHT: emerging results Dr Rachel Taylor on behalf of the BRIGHTLIGHT Team.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
© Cancer Research UK 2007 Registered charity number Figure One: The vulva and vagina.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
Consultant Obstetrician & Gynaecologist
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
South West Public Health Observatory South West Regional Public Health Group Opportunities for future analysis by SWPHO Sean McPhail South West Public.
Trends in prostate cancer and its management in the South West Region, Hampshire and the Isle of Wight Christine Harling Julia Verne (SWPHO) Roy Maxwell.
ACCESS TO PALLIATIVE CARE FOR UPPER GI CANCER PATIENTS A SURVEY OF 5 CANCER NETWORKS DR Bailey 1 C Wood 2 and M Goodman 3.
RARE SKIN TUMOURS IN THE SOUTH WEST J Weeks, V Poirier, J Verne, C Harling on behalf of the Skin Cancer Tumour Panel Objective NICE Improving Outcomes.
TRIAL PARTICIPATION IN THE OVER 60s: A RE-AUDIT OF THE MANAGEMENT OF AML IN THE SOUTH WEST OF ENGLAND South West Cancer Intelligence Service
Gynaecological Oncology Patient Pathway Cecile Bergzoll Gynaecological Oncologist Wellington.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
REGIONAL GASTROSTOMY AUDIT FOR HEAD AND NECK CANCER D Bailey 1 D Baldwin 2, S Caldera 3 Cancer Intelligence Service, South.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Squamous Cell Carcinoma
Oesophago–Gastric Cancer Audit
Oesophago–Gastric Cancer
NON-SMALL CELL LUNG CANCER
National Oesophago–Gastric Cancer Audit 2015.
Daniel Keith – Dermatology Registrar
Curative treatment rates for patients diagnosed with
Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.
Oesophago–Gastric Cancer
Management of Vulval Melanoma
Hannah Marder Cancer Manager UH Bristol
Results from the first National Lung Cancer Organisational Audit.
‘Improving Outcomes for people with skin tumours, including Melanoma’
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Regional Melanoma & Complex Skin Cancer Meeting
Airedale NHS Foundation Trust
Presentation transcript:

Management of Vulval Cancer Services in South West England Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour Panel September 2004

2 4 Cancer Networks Peninsula 3 Counties ASWCS Dorset SWIS Gynaecology Tumour Panel Multidisciplinary membership

3 Background Calman Hine Report 1995 Improving Outcomes Guidance Gynaecological Cancer 1999 SWCIS Regional Standards & Guidelines (Royal College Pathologists/ Obstetricians & Gynaecologists) -> improvement in care and outcomes ?

4 Aim of the Audit Monitor treatment against standards Have outcomes improved? UKCCR 2004

5 Standards Managed by gynaecologist with special interest in oncology (Regional/IOG) Minimum dataset recorded (IOG) eg Histological Type Grade ASA Groin nodes taken if Stage >IA (Regional) Skin - clear margins from tumour ≥ 8mm (Regional)

6 Method All new diagnoses squamous carcinoma of vulva (1997 to 2002) Data collected by gynaecology specialist nurses, gynaecologists, oncologists & audit departments Supplementary data from SWCIS information systems

7 Results 1997 – 2002: 435 cases squamous cell carcinoma (18 verrucous subtype) Surgery 80% radiotherapy 9% Stage I 33% Stage II 28% Stage III 16% Stage IV 6% not stated 16%

8 Age & Stage at diagnosis

9 % Surgery by ‘gynaecologist with oncology interests’

10 % Recorded (Min Data Set) CohortASAStageGrade %87%91% 99 – 0077%80%88% %83%92%

11 Width Tumour-free margins Ops/Cons

12 % operations ≥ 8mm margin by Consultant ‘activity level’ Ops/Cons

13 Nodes Taken (≥ Stage IB) Ops/Cons

to 2000 Kaplan-Meier survival estimates, by age category Ops/Cons Years since treatment <70years>70 and <80years >80 years

to 2000 Survivor functions, by stage adjusted for age Ops/Cons Years since treatment Stage IStage II Stage IIIStage IV not stated

to 2000 Survivor functions, by Treatment Year adjusted for age Years since treatment

17 Conclusion Centralisation of surgery has occurred Improvements in practice - not yet Improvements in outcome – too soon to say?

18 Thank you